"it's up to patients to educate themselves and their doctors about these life-saving treatments."There is much we can learn by advocacy and research, and much from homeopathic medicine.
There is much success in conventional medicine but there are times when treatments, like chemotherapy, that makes a patient sicker, not better. My ex-late-first husband was a prime example. He died of a heart attack mid-treatment. As was my late mother, whose treatments, I believe, hastened her death.
There are clinical trials which we can access. There are also missing simple solutions that the medical profession eschews. Especially, in the United States where health insurance companies are busy trying to increase profits. It is important to understand your options.
I found this out when reading The Clinic of Hope, the story of Rene Caisse. A Canadian story of doctors who refused to believe that an Ontario nurse could possibly be helping patients.
Doctors are concerned only with published clinical trials, and not any homeopathic medicines. For clinical trials are only done on a select population patients (seniors are often excluded). I simply do not trust pharmaceutical companies, who pay for the research. It simply isn't in their best interests to publish unfavourable results.
Julia Schopick gives us wise counsel in her book:
-- How to know if a "miracle cure" you read about is snake oil or the real deal
-- How to talk to your doctor about a promising treatment option you learned about
-- What to do if your doctor dismisses your idea.
The treatments featured in Honest Medicine are Silverlon for nonhealing wounds; Low Dose Naltrexone (LDN) for autoimmune diseases such as MS, lupus, rheumatoid arthritis and Crohn's disease; the Ketogenic Diet for childhood epilepsy; and intravenous alpha lipoic acid for terminal liver disease.
Julia Schopick spoke over Labor Day Weekend (2011) at the Cancer Control Society's 39th Annual Convention in Los Angeles. She spoke about the treatments she features in her book, "Honest Medicine": Low Dose Naltrexone for autoimmune diseases, the Ketogenic Diet for pediatric epilepsy, Intravenous Alpha Lipoic Acid for liver disease, and Silverlon for non-healing wounds.
The pharmaceuticals get the money, and the press. For example, an expensive drug by Novartis,FTY720, a novel oral therapy in development for MS (PDF), shows sustained
benefits for the majority of patients after three years of treatment.
Dr. Jill Smith’s original article, "Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease," in the January issue of the American Journal of Gastroenterology (2007;102:1–9)